Free practice quiz
CMAP Prep Course (CMAP): free quiz
10 questions from the program. See your score right away, then unlock the explanation of every answer.
- Question 1 of 10A CMAP candidate is reviewing D1-D9 course domains using a practice MAR entry: metoprolol tartrate 25 mg by mouth twice daily for Mr. Lane. Which study tag best reflects the CMAP blueprint surrogate and role boundaries?Option C is correct: CMAP domains organize safe delegated medication work—verify the MAR and label, administer only as authorized, observe, document, and report concerns. Option A is tempting because metoprolol may require clinical monitoring, but deciding continuation is outside the aide role. Option B is tempting because dizziness is relevant, but dose changes require licensed direction. Option D is eliminated because diagnosis and treatment decisions are not CMAP functions. Review CMAP Domain Structure — focus on domain tags as safety, verification, observation, reporting, and escalation cues.
- Question 2 of 10
During the 8 AM medication pass, the MAR lists lisinopril 20 mg PO daily for resident Jordan Lee. The pharmacy label on the bottle reads lisinopril 10 mg PO daily. The resident confirms name and date of birth. What is the safest next action for the medication aide?
A is correct: a mismatch between the MAR and label is a medication-safety red flag; the aide should not choose a dose and must escalate to the supervising nurse. C is tempting because labels are important, but a label-MAR mismatch requires clarification. B is tempting because it matches the MAR, but changing tablet quantity to resolve a discrepancy exceeds delegated authority. D is unsafe because memory or coworker recall is not an authorized order source. The safe framework is: identify the task, compare MAR and label, stop for discrepancy, report, and document factually.
- Question 3 of 10
During the 8:00 AM medication pass, the MAR lists Ms. Lila Hart: metformin 500 mg tablet by mouth twice daily with meals. The pharmacy label matches the drug, dose, route, and resident. The resident says, “I cannot swallow pills today,” and there is no order to crush the tablet. A television in the room is loud, and breakfast is delayed 10 minutes. What is the safest next action within the medication aide role?
B is correct. Swallowing difficulty and no authorization to alter the dosage form are red flags; the aide should stop, keep the medication secured, and report to the supervising nurse. D focuses on irrelevant details and ignores the unsafe route problem. A is tempting because crushing may seem helpful, but altering a tablet requires authorization and policy support. C is unsafe because bedside storage and inaccurate “refusal” documentation do not match the facts. The key facts are drug, dose, route, resident identity, timing, and special instructions or safety concerns.
- Question 4 of 10
The MAR entry reads: “Metoprolol tartrate 25 mg tablet, give 1 tablet PO BID for hypertension.” Before giving the 8 AM dose, a resident asks what “PO BID” means. Which response uses correct medication terminology within the medication aide role?
Option D is correct: “PO” is the route, “BID” is frequency, and 25 mg is the dose/strength being administered per the MAR. Option A is tempting because “PRN” means as needed, but “PO” does not; hypertension is the indication. Option B confuses route with indication and frequency. Option B is unsafe because topical administration and doubling tablets change the ordered route and dose. Medication aides should use facility-approved terms and clarify any unclear abbreviation with the supervising nurse before administration.
- Question 5 of 10
During a supervised medication pass, the MAR lists lisinopril 10 mg PO once daily at 0900 for resident Maria L. The bubble-pack label reads lisinopril 20 mg PO once daily. The resident says, “I usually take the small pink pill.” What is the safest next action within the medication aide role?
C is correct: the right dose must match the authorized order and label before administration; a discrepancy requires stopping and reporting. A is tempting because it seems to make 10 mg, but splitting or altering a tablet is not allowed unless authorized by policy and labeling. B ignores the dose mismatch. D uses resident memory instead of verified medication rights. Medication aides should verify, withhold when safety policy requires, notify the licensed nurse, and document factually.
- Question 6 of 10
In an assisted living facility, a medication aide is preparing Mrs. Lane’s acetaminophen 650 mg by mouth every 6 hours as needed from the MAR. After helping another resident adjust a nasal cannula, the aide puts on clean gloves and reaches for the medication package without cleaning hands. What is the safest next action within the medication aide role?
A is correct: hand hygiene before medication handling reduces transfer of organisms to packaging, equipment, and the resident. B is tempting because gloves are visible protection, but gloves do not replace hand hygiene. D addresses the package only and misses contaminated hands. C documents an error but does not prevent contamination. The medication aide should stop, clean hands per policy, then resume authorized checks and administration.
- Question 7 of 10
You are assigned to give medications in an assisted living facility. The MAR shows morphine sulfate 2 mg IV every 4 hours PRN pain for Mr. Ellis. Your medication aide training and facility policy authorize only oral, topical, ophthalmic, and otic routes. What is the safest next step?
D is correct: delegation does not expand a medication aide’s authority; an unauthorized IV route requires stopping and notifying the supervising licensed nurse. B is tempting because the MAR lists a valid-looking order, but route authorization and facility policy must also be met. C is unsafe because changing route or formulation is a prescriber/nurse/pharmacy issue, not an aide decision. A is inaccurate documentation; the issue is not refusal but inability to administer within scope. Medication aides should perform only delegated tasks allowed by training, law, and policy, and report safety barriers promptly.
- Question 8 of 10
During a busy morning medication pass, the MAR lists metoprolol tartrate 25 mg by mouth twice daily for Jordan Lee. The blister pack in the drawer is labeled metoprolol tartrate 50 mg tablets for Jordan Lee, take one tablet by mouth twice daily. Several residents are waiting. What is the safest next step within the medication aide role?
Correct: A. Resident safety overrides speed; a label-to-MAR dose mismatch means the aide cannot confirm the right dose and must stop and report. C is unsafe because matching name/drug does not resolve the dose discrepancy. D is tempting mathematically, but splitting or altering a tablet requires authorization and policy confirmation. A avoids giving a possibly wrong dose, but failing to report and document factually can delay care and conceal a discrepancy. Medication administration standards emphasize the rights/checks, comparing orders with labels, and immediate communication of errors or near misses.
- Question 9 of 10During the 8:00 AM medication pass, the MAR lists metoprolol tartrate 25 mg by mouth twice daily for Ms. L, a fictional resident. After you confirm her identity, she says, “I don’t want that pill; it makes me nervous.” Which response best supports respectful medication communication within the CMAP role?Option C is correct because medication aides should use clear, respectful, task-related communication, respect a resident’s right to refuse, report the refusal or concern, and document per policy. Option A pressures the resident and undermines cooperation. Option C gives patient-specific reassurance beyond the aide role and may be inaccurate. Option D is deceptive and unsafe; medications must not be hidden or given without the resident’s informed cooperation unless a specific lawful care plan and policy apply. The safe action is to stop, report facts to the supervising nurse, and document accurately.
- Question 10 of 10
During the morning pass, you compare the MAR with a medication label. The MAR entry reads: “lisinopril 10 mg by mouth once daily,” but the resident identifier field is blank and the printed order copy is hard to read. The label shows the same drug, dose, route, and frequency. What is the safest next action within the medication aide role?
Correct: B. Core order elements include resident identifier, medication name, dose, route, and frequency; missing or illegible information requires clarification before administration. D is unsafe because matching drug details do not replace resident verification. C is unsafe because an aide must not fill in omitted order details from memory. A is unsafe because another aide’s verbal confirmation is not an authorized order source unless facility policy specifically permits it. The medication should be secured, the administration withheld for safety, and the supervising licensed nurse notified.
See why each answer is right or wrong
Enter your email to unlock the explanation of every question, free.